Introduction: The main objective of gender reassignment surgery (GRS) in male to female (MtF) transgender people is to create a functional and aesthetic vagino-clitoral complex. Here we report on a modified preparation of the neurovascular bundle (NVB). Materials and Methods: Between May 2011 and September 2014, 96 consecutive MtF transgender patients underwent GRS at our department. Sensitivity of the neoclitoris was assessed afterwards. Results were compared with a historical cohort from our department (2004-2010, n = 119) in which perioperative treatment was the same except for the preparation of the NVB. Results: In 92 (95.8%) and 78 (81.2%) patients information on neoclitoral sensitivity was available and in 79 (82.3%) and 69 (71.9%) sensitivity was tested semiquantatively after first and second stage procedure respectively. A semiquantitative grading system correlated significantly with intermedium-term ability to achieve orgasms (p = 0.036). The modification led to a reduction in operation time by an average of 61 min. With the modified technique, we had a higher rate of postoperative local hematoma but with no need for further intervention. Conclusions: Preparation is safe and time saving both preserving the neoclitoral sensitivity and promoting a preferably feminine aspect of the mons pubis. Semiquantitative testing of sensitivity correlates with the intermedium-term capability of achieving orgasms.

Keywords:
Sensitivity, Gender reassignment surgery, Male to female, Transgender, Neurovascular bundle
1.
Becker S, Bosinski HAG, Clement U, Eicher W, Goerlich TM, Hartmann U, Kockott G, Langer D, Preuss WF, Schmidt G, Springer A, Wille R: Behandlung und Begutachtung von Transsexuellen. Standards der Deutschen Gesellschaft für Sexualforschung, der Akademie für Sexualmedizin und der Gesellschaft für Sexualwissenschaft. Psychotherapeut 1997;42:256-262.
2.
Senf W: Transsexualität. Psychotherapeut 2008;53:316-327.
3.
Hage JJ, Karim RB: Ought GIDNOS get nought? Treatment options for nontranssexual gender dysphoria. Plast Reconstr Surg 2000;105:1222-1227.
4.
De Cuypere G, T'Sjoen G, Beerten R, Selvaggi G, De Sutter P, Hoebeke P, Monstrey S, Vansteenwegen A, Rubens R: Sexual and physical health after sex reassignment surgery. Arch Sex Behav 2005;34:679-690.
5.
Gijs L, Brewaeys A: Surgical treatment of gender dysphoria in adults and adolescents: recent developments, effectiveness, and challenges. Annu Rev Sex Res 2007;18:178-224.
6.
Klein C, Gorzalka BB: Sexual functioning in transsexuals following hormone therapy and genital surgery: a review. J Sex Med 2009;6:2922-2939; quiz 2940-2941.
7.
Pfäfflin F, Junge A: Geschlechtsumwandlung - Abhandlungen zur Transsexualität. Stuttgart, Schattauer Verlag, 1998.
8.
Hess J, Rossi Neto R, Panic L, Rubben H, Senf W: Satisfaction with male-to-female gender reassignment surgery. Dtsch Arztebl Int 2014;111:795-801.
9.
Imbimbo C, Verze P, Palmieri A, Longo N, Fusco F, Arcaniolo D, Mirone V: A report from a single institute's 14-year experience in treatment of male-to-female transsexuals. J Sex Med 2009;6:2736-2745.
10.
Perovic SV, Stanojevic DS, Djordjevic ML: Vaginoplasty in male transsexuals using penile skin and a urethral flap. BJU Int 2000;86:843-850.
11.
Happich FJ: Postoperative Ergebnisse bei Transsexualität unter besonderer Beruecksichtigung der Zufriedenheit - eine Nachuntersuchung. Universität Essen-Duisburg, 2006.
12.
Lowenberg H, Lax H, Rossi Neto R, Krege S: Complications, subjective satisfaction and sexual experience by gender reassignment surgery in male-to-female transsexuality. Z Sexualforsch 2010;23:328-347.
13.
Krege S, Bex A, Lummen G, Rubben H: Male-to-female transsexualism: a technique, results and long-term follow-up in 66 patients. BJU Int 2001;88:396-402.
14.
Sohn MH, Hatzinger M, Wirsam K: Genital reassignment surgery in male-to-female transsexuals: do we have guidelines or standards? Handchir Mikrochir Plast Chir 2013;45:207-210.
15.
Coleman E, Bockting W, Botzer M, Cohen-Kettenis PT, DeCuypere G, Feldman J, Fraser L, Green J, Knudson G, Meyer WJ, et al: Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgenderism 2012;13:165-232.
16.
Tsoi WF: The prevalence of transsexualism in Singapore. Acta Psychiatr Scand 1988;78:501-504.
17.
Vujovic S, Popovic S, Sbutega-Milosevic G, Djordjevic M, Gooren L: Transsexualism in Serbia: a twenty-year follow-up study. J Sex Med 2009;6:1018-1023.
18.
Olyslager F, Conway L: On the Calculation of the Prevalence of Transsexualism. Chicago, WPATH 20th International Symposium, 2007, p 26.
19.
Karim RB, Hage JJ, Mulder JW: Neovaginoplasty in male transsexuals: review of surgical techniques and recommendations regarding eligibility. Ann Plast Surg 1996;37:669-675.
20.
de Vries AL, McGuire JK, Steensma TD, Wagenaar EC, Doreleijers TA, Cohen-Kettenis PT: Young adult psychological outcome after puberty suppression and gender reassignment. Pediatrics 2014;134:696-704.
21.
Kraemer B, Delsignore A, Schnyder U, Hepp U: Body image and transsexualism. Psychopathology 2008;41:96-100.
22.
Baranyi A, Piber D, Rothenhausler HB: [Male-to-female transsexualism. Sex reassignment surgery from a biopsychosocial perspective]. Wien Med Wochenschr 2009;159:548-557.
23.
Sohn M, Bosinski HA: Gender identity disorders: diagnostic and surgical aspects. J Sex Med 2007;4:1193-1207; quiz 1208.
24.
Weitze C, Osburg S: Transsexualism in Germany: empirical data on epidemiology and application of the German Transsexuals' Act during its first ten years. Arch Sex Behav 1996;25:409-425.
25.
Pelliccioni G, Piloni V, Sabbatini D, Fioravanti P, Scarpino O: Sex differences in pudendal somatosensory evoked potentials. Tech Coloproctol 2014;18:565-569.
26.
Eldh J: Construction of a neovagina with preservation of the glans penis as a clitoris in male transsexuals. Plast Reconstr Surg 1993;91:895-900; discussion 901-903.
27.
Giraldo F, Esteva I, Bergero T, Cano G, Gonzalez C, Salinas P, Rivada E, Lara JS, Soriguer F; Andalusia Gender Team: Corona glans clitoroplasty and urethropreputial vestibuloplasty in male-to-female transsexuals: the vulval aesthetic refinement by the andalusia gender team. Plast Reconstr Surg 2004;114:1543-1550.
28.
Amend B, Seibold J, Toomey P, Stenzl A, Sievert KD: Surgical reconstruction for male-to-female sex reassignment. Eur Urol 2013;64:141-149.
29.
Rubin SO: Sex-reassignment surgery male-to-female. Review, own results and report of a new technique using the glans penis as a pseudoclitoris. Scand J Urol Nephrol Suppl 1993;154:1-28.
30.
Salvador J, Massuda R, Andreazza T, Koff WJ, Silveira E, Kreische F, de Souza L, de Oliveira MH, Rosito T, Fernandes BS, et al: Minimum 2-year follow up of sex reassignment surgery in Brazilian male-to-female transsexuals. Psychiatry Clin Neurosci 2012;66:371-372.
31.
Lawrence AA: Sexuality before and after male-to-female sex reassignment surgery. Arch Sex Behav 2005;34:147-166.
32.
Selvaggi G, Monstrey S, Ceulemans P, T'Sjoen G, De Cuypere G, Hoebeke P: Genital sensitivity after sex reassignment surgery in transsexual patients. Ann Plast Surg 2007;58:427-433.
33.
Ross MW, Need JA: Effects of adequacy of gender reassignment surgery on psychological adjustment: a follow-up of fourteen male-to-female patients. Arch Sex Behav 1989;18:145-153.
34.
Eicher W, Schmitt B, Bergner CM: Darstellung der Methode und Nachuntersuchun von 50 Operierten. Z Sexualforsch 1991;4:e14.
35.
van Noort DE, Nicolai JP: Comparison of two methods of vagina construction in transsexuals. Plast Reconstr Surg 1993;91:1308-1315.
36.
Blanchard R, Legault S, Lindsay WR: Vaginoplasty outcome in male-to-female transsexuals. J Sex Marital Ther 1987;13:265-275.
37.
Hage JJ, Karim RB: Sensate pedicled neoclitoroplasty for male transsexuals: Amsterdam experience in the first 60 patients. Ann Plast Surg 1996;36:621-624.
38.
Rehman J, Lazer S, Benet AE, Schaefer LC, Melman A: The reported sex and surgery satisfactions of 28 postoperative male-to-female transsexual patients. Arch Sex Behav 1999;28:71-89.
39.
Lawrence AA: Patient-reported complications and functional outcomes of male-to-female sex reassignment surgery. Arch Sex Behav 2006;35:717-727.
40.
Bentler PM: A typology of transsexualism: gender identity theory and data. Arch Sex Behav 1976;5:567-584.
41.
Schroder M, Carroll RA: New women: sexological outcomes of male-to-female gender reassignment surgery. J Sex Educ Ther 1999;24:137-146.
42.
Rakic Z, Starcevic V, Maric J, Kelin K: The outcome of sex reassignment surgery in Belgrade: 32 patients of both sexes. Arch Sex Behav 1996;25:515-525.
43.
Jarrar K, Wolff E, Weidner W: Langzeitergebnisse nach Geschlechtsangleichung bei männlichen Transsexuellen. Urologe A 1996;35:7.
44.
Goddard JC, Vickery RM, Qureshi A, Summerton DJ, Khoosal D, Terry TR: Feminizing genitoplasty in adult transsexuals: early and long-term surgical results. BJU Int 2007;100:607-613.
45.
Lindemalm G, Korlin D, Uddenberg N: Long-term follow-up of ‘sex change' in 13 male-to-female transsexuals. Arch Sex Behav 1986;15:187-210.
46.
Lief HI, Hubschman L: Orgasm in the postoperative transsexual. Arch Sex Behav 1993;22:145-155.
47.
Daley BJ, Cecil W, Clarke PC, Cofer JB, Guillamondegui OD: How slow is too slow? Correlation of operative time to complications: an analysis from the Tennessee Surgical Quality Collaborative. J Am Coll Surg 2015;220:550-558.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.